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Abstract
Background: In recent years, the associations between vitamin D status and Alzheimer’s disease (AD) and
dementia have gained increasing interests. The present meta-analysis was designed to estimate the association
between vitamin D deficiency and risk of developing AD and dementia.
Methods: A literature search conducted until February 2015 identified 10 study populations, which were included
in the meta-analysis. Pooled risk ratios (RRs) and 95 % confidence interval (CI) were calculated with a random-effect
model using Stata software package.
Results: Results of our meta-analysis showed that subjects with deficient vitamin D status (25(OH)D level < 50 nmol/L)
were at increased risk of developing AD by 21 % compared with those possessing 25(OH)D level > 50 nmol/L. Similar
analysis also found a significantly increased dementia risk in vitamin D deficient subjects. There is no evidence for
significant heterogeneity among the included studies.
Conclusion: Available data indicates that lower vitamin D status may be associated with increased risk of developing
AD and dementia. More studies are needed to further confirm the associations and to evaluate the beneficial effects of
vitamin D supplementation in preventing AD and dementia.
Introduction
Alzheimer’s disease (AD) is the most common form of
dementia in the elderly. With the accelerating popula-
tion aging process, the prevalence of AD and dementia
is estimated to rise steadily [1, 2]. Despite considerable
effort has been devoted to the drug discovery for AD,
there is no effective agent to combat it at present. Thus,
it is urgent to identify specific modifiable risk factors for
these disorders.
In recent years, the associations between vitamin D
and AD or dementia have attracted growing interests
[3–5]. First, accumulating studies indicate that vitamin
D deficiency is prevalent in AD and dementia patients
[6, 7] and a meta-analysis study supported that AD
patients possess lower level of 25-hydroxyvitamin D
[25(OH)D] compared with age-matched healthy con-
trols [8]. Second, low 25(OH)D level may be a potential
risk factor of developing AD and dementia as sup-
ported by recent studies [9, 10]. However, there is a
lack of a comprehensive evaluation on whether vitamin
D deficiency correlates with high risk of AD and de-
mentia development, which has important implications
for the prevention of these disorders. Therefore, the
present study was designed to estimate the association
between vitamin D deficiency and risk of developing
AD and dementia.
Methods
Search strategy and study selection
The meta-analysis was performed according to the
PRISMA guidelines. With the keywords “Alzheimer’s dis-
ease” or “dementia” and “vitamin D” or “25(OH)D”, the
literature search was conducted in the MEDLINE data-
base from inception until February 2015. The references
lists of retrieved articles were also manually reviewed to
identify relevant studies missed by the search strategy.
The potentially relevant references were identified for in-
clusion by reviewing titles and/or abstracts, and/or full
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text of all citations identified with database searches.
Vitamin D deficiency was defined as a serum 25(OH)D, a
stable marker of vitamin D status, concentration of ≤
50 nmol/L, which has been widely used in relative studies
as the cut-off point for vitamin D deficiency [11]. For
consistency, serum concentrations of 25(OH)D present in
nmol/L were converted to ng/mL by using the conversion
factor (1 ng/mL = 2.5 nmol/L).
The eligible studies must meet the following inclusion
criteria: i) original studies to evaluate the association of
vitamin D status and risk of developing AD or dementia;
ii) providing the odds ratios (ORs), relative risks (RRs)
or hazard ratios (HRs) with 95 % confidence intervals
(CI) of developing AD or dementia in vitamin D defi-
cient subjects comparing with subjects with serum
25(OH)D concentration of > 50 nmol/L. The animal ex-
periment, review and mechanistic research studies were
excluded. Duplicate articles were excluded in the study.
Only references published in English is considered.
Data extraction and analysis
The collected information from each identified study in-
clude: the first author, year of publication, country, aver-
age age, OR, and 95 % CI, and adjusted factors. Two
reviewers extracted the data from each study independ-
ently and finally verified the extracted data. The meta-
analysis was performed using the Stata statistical software
package, version 12.0 (StataCorp, College Station, Texas,
USA). The random effect model was employed during all




The study selection flowchart was detailed in Fig. 1.
Overall, 526 potentially relevant references were initially
identified through database search and 298 were obtained
for further screen after duplicates removed. Following ini-
tial titles and/or abstracts screening 226 references were ex-
cluded. After full text assessment of the remained articles
five studies, which include 10 study populations, were iden-
tified and included in the present analysis [9, 10, 12–14].
For the five eligible studies, two studies are prospective co-
hort and three are cross-sectional studies. Five eligible stud-
ies were conducted in Denmark, USA, UK, France and
Germany, respectively. All included studies were published
in English. The years of publication ranged from 2010 to
2015.
Vitamin D deficiency and risk of AD
Five study populations from three studies were included
in the meta-analysis of the association between vitamin
D deficiency and risk of developing AD [9, 10, 12]. Main
characteristics of the included studies were provided in
Table 1. Forest plot of the included studies investigating
risk of AD in vitamin D deficient subjects was shown in
Fig. 2. Results of the prospective cohort studies showed
that vitamin D deficiency was associated with increased
risk of AD occurrence compared to the subjects with
25(OH)D level > 50 nmol/L, overall OR = 1.21, 95 % CI
1.01–1.40. The I2 value was 0.0 %, which suggested that
there was no evidence for significant heterogeneity. The
inclusion of one cross-sectional study negligibly affected
the results (Fig. 2).
Vitamin D deficiency and risk of dementia
Table 2 provided the summary of the included studies
concerning vitamin D deficiency and risk of developing
dementia [9, 12–14]. Meta-analysis of the prospective
cohort studies showed that the risk of developing de-
mentia was increased by 63 % in comparison with the
subjects with 25(OH)D level > 50 nmol/L according to
the estimated OR = 1.63, 95 % CI 1.09–2.16 (Fig. 3).
Similar results were observed from meta-analysis re-
stricted to prospective cohort studies (OR = 1.48, 95 %
CI 0.63–2.33) and the I2 value suggested that there was
no evidence for significant heterogeneity among the
studies (Fig. 3).
Discussion
As a fat-soluble steroid hormone, vitamin D possesses a
wide range of health-promoting effects and has potential
therapeutic benefits in combating many disorders, includ-
ing the non-skeletal, age-associated disorders [15–17]. In
recent years, the associations between vitamin D and
AD or dementia have attracted increasing attentions
[3–5, 18–21]. The meta-analysis by Etgen et al. found
that participants with low vitamin D status showed an
increased risk of cognitive impairment compared with
Fig. 1 Flowchart of selection of the references for inclusion in
meta-analysis
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normal vitamin D status [22]. Similarly, Balion et al.
found that AD patients had a lower vitamin D concentra-
tion compared with controls and participants with higher
vitamin D concentrations had a higher average Mini-
Mental State Examination score through meta-analyses
[23]. The present study was designed to further explore
whether low vitamin D status predicts increased incidence
of AD and dementia. The data showed that subjects with
deficient vitamin D (serum 25(OH)D level ≤ 50 nmol/L)
were at higher risk for the development of AD and
Table 1 Summary characteristics of studies included in the analysis of vitamin D deficiency and risk of AD
References Year Country Study type Participants Average age
(years)
OR 95 % CI 25(OH)D
(nmol/L)
Adjustment
Afzal [10] 2014 Denmark Prospective
cohort
2384 - 1.25 0.95–1.64 <25 Age, sex, month of blood sample, smoking
status, body mass index, leisure time and
work-related physical activity, alcohol
consumption, income level, education,
baseline diabetes mellitus, hypertension,
cholesterol, high-density lipoprotein
cholesterol, and creatinine
Afzal [10] 2014 Denmark Prospective
cohort
4087 - 1.12 0.90–1.4 25–50 Age, sex, month of blood sample, smoking
status, body mass index, leisure time and
work-related physical activity, alcohol
consumption, income level, education,
baseline diabetes mellitus, hypertension,
cholesterol, high-density lipoprotein
cholesterol, and creatinine
Littlejohns [9] 2014 UK Prospective
cohort
1615 73.6 ± 4.5 2.22 1.02–4.83 <25 Age, season of vitamin D collection,
education, sex, BMI, smoking, alcohol
consumption, and depressive symptoms
Littlejohns [9] 2014 UK Prospective
cohort
1615 73.6 ± 4.5 1.69 1.06–2.69 25–50 Age, season of vitamin D collection,
education, sex, BMI, smoking, alcohol
consumption, and depressive symptoms
Buell [12] 2010 USA Cross-sectional 318 73.5 ± 8.1 2.65 0.99–7.16 ≤50 Age, race, sex, body mass index, and
education, kidney function, multivitamin
use, season, diabetes, hypertension,
plasma homocysteine, and ApoE allele
status
Fig. 2 Forest plot of the included studies investigating risk of developing AD in vitamin D deficient subjects. The size of each square is proportional to
the study’s weight
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dementia in comparison with those with serum 25(OH)D
level > 50 nmol/L. Findings of this meta-analysis are indir-
ectly supported by a recent study covering 5010 subjects
free of dementia at baseline indicating that higher vitamin
D concentration is associated with lower dementia risk
after a 17-year follow up [20].
Attempts have been made to explore the effects of vita-
min D supplementation in preventing AD or dementia in
recent years, while the results are inconsistent [24–26]. In
a prospectively followed cohort study of 498 older women
aged 75 years and older, it was found that higher vita-
min D dietary intake can lower the risk of developing
AD after a 7 years follow-up [24]. In comparison, in a
randomized double-blind placebo-controlled trial recruiting
4143 women aged 65 and older without probable dementia
at baseline, no association between vitamin D combined
with calcium carbonate treatment supplement and inci-
dent cognitive impairment was observed [26]. Thus, fur-
ther studies recruiting a large number of participants by
considering the gender and ethnic differences and with
Table 2 Summary characteristics of studies included in the analysis of vitamin D deficiency and risk of dementia
References Year Country Study type Participants Average age
(years)
OR 95 % CI 25(OH)D
(nmol/L)
Adjustment
Littlejohns [9] 2014 UK Prospective
cohort
1547 73.6 ± 4.5 2.25 1.23–4.13 <25 Age, season of vitamin D collection,
education, sex, BMI, smoking, alcohol
consumption, and depressive symptoms
Littlejohns [9] 2014 UK Prospective
cohort
1547 73.6 ± 4.5 1.53 1.06–2.21 25–50 Age, season of vitamin D collection,
education, sex, BMI, smoking, alcohol
consumption, and depressive symptoms
Buell [12] 2010 USA Cross-sectional 318 73.5 ± 8.1 2.21 1.13–4.32 ≤50 Age, race, sex, body mass index, and
education, kidney function, multivitamin
use, season, diabetes, hypertension, plasma
homocysteine, and ApoE allele status
Annweiler [13] 2011 France Cross-sectional 288 86.0 ± 0.4 2.57 1.05–6.27 <25 Fully adjusted but without detailed
information
Nagel [14] 2015 Germany Cross-sectional 1373 75.6 ± 6.57 1.08 0.60–1.92 ≤50 Adjusted for age, sex, school education,
smoking status, season, alcohol
consumption, BMI, and history of
depression
Fig. 3 Forest plot of the included studies investigating risk of developing dementia in vitamin D deficient subjects. The size of each square is
proportional to the study’s weight
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different vitamin D dosages are encouraged to evaluate
the efficacy of vitamin D supplementations in preventing
AD and dementia.
Some limitations in the present meta-analysis need to
be considered. First, the number of eligible studies is
relatively small. Second, men and women have different
AD incidence overall [27, 28], while there are not
enough data to perform gender subgroup analysis to ex-
plore the effect of gender on the association between
vitamin D deficiency and risk of developing AD. Third,
the available data cannot permit us to exclude the possi-
bility that the associations between vitamin D and AD
or dementia are a result of disease development rather
than being causal.
Conclusions
In summary, available data shows that vitamin D defi-
ciency may be associated with increased risk of develop-
ing AD and dementia. There is a strong need to further
confirm the associations by more prospective cohort
studies. In addition, in view of the safe and cost-effective
interventions to improve vitamin D status, the potential
beneficial effects of vitamin D supplementation in pre-
venting AD and dementia should be paid attention to
and assessed by the neurologists and geriatricians.
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